Ticker Details
Aligos Therapeutics, Inc.
IPO Date:	October 16, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$43.03M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.45 | 4.85%
Avg Daily Range (30 D):	$0.29 | 5.18%
Avg Daily Range (90 D):	$0.28 | 4.59%

Institutional Daily Volume
Avg Daily Volume:	.21M
Avg Daily Volume (30 D):	.24M
Avg Daily Volume (90 D):	.22M

Trade Size
Avg Trade Size (Sh.):	148
Avg Trade Size (Sh.) (30 D):	85
Avg Trade Size (Sh.) (90 D):	81

Institutional Trades
Total Institutional Trades:	104
Avg Institutional Trade:	$2.35M
Avg Institutional Trade (30 D):	$.56M
Avg Institutional Trade (90 D):	$.56M
Avg Institutional Trade Volume:	.01M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.3M
Avg Closing Trade (30 D):	$.69M
Avg Closing Trade (90 D):	$.69M
Avg Closing Volume:	13.54K

News

May 27, 2026 @ 6:30 AM Aligos Therapeutics Presents Positive Data at the ... Source: Not Specified

Apr 16, 2026 @ 10:00 AM Aligos Therapeutics Enters into Exclusive License ... Source: Na

Mar 5, 2026 @ 1:00 PM Aligos Therapeutics Reports Recent Business Progre... Source: Aligos Therapeutics, Inc.

Feb 23, 2026 @ 1:00 PM Aligos Therapeutics Presents Positive Data at the ... Source: Not Specified

Jan 30, 2026 @ 1:00 PM Aligos Therapeutics Announces Inducement Grants Un... Source: Na

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-7.4	$-.14	$-2.21
Diluted EPS	$-7.4	$-.14	$-2.21
Revenue	$31.52M	$27.78M	$2.83M
Gross Profit
Net Income / Loss	$-75.96M	$-1.5M	$-23.04M
Operating Income / Loss	$-78.99M	$-1.89M	$-26.93M
Cost of Revenue
Net Cash Flow	$11.65M	$.27M	$11.74M
PE Ratio

Splits
Aug 19, 2024	1:25